Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program.
Gonzalez PE, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon ME, Waldo SW, Pfau SE, Curtis JP, Shah SM. Gonzalez PE, et al. Among authors: hussain y. Am J Cardiol. 2024 Jul 1;222:39-50. doi: 10.1016/j.amjcard.2024.04.039. Epub 2024 Apr 26. Am J Cardiol. 2024. PMID: 38677666
Pulmonary Artery Catheter Use and Outcomes in Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock Treated With Impella (a Nationwide Analysis from the United States).
Ismayl M, Hussain Y, Aboeata A, Walters RW, Naidu SS, Messenger JC, Basir MB, Rao SV, Goldsweig AM, Altin SE. Ismayl M, et al. Among authors: hussain y. Am J Cardiol. 2023 Sep 15;203:304-314. doi: 10.1016/j.amjcard.2023.06.117. Epub 2023 Jul 28. Am J Cardiol. 2023. PMID: 37517125
Outcomes of Percutaneous Coronary Intervention for Protected versus Unprotected Left Main Coronary Artery Disease: Insights from the VA CART Program.
Gonzalez PE, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon ME, Waldo SW, Pfau SE, Curtis JP, Shah SM. Gonzalez PE, et al. Among authors: hussain y. medRxiv [Preprint]. 2023 Oct 28:2023.10.27.23297698. doi: 10.1101/2023.10.27.23297698. medRxiv. 2023. Update in: Am J Cardiol. 2024 Jul 1;222:39-50. doi: 10.1016/j.amjcard.2024.04.039 PMID: 37961093 Free PMC article. Updated. Preprint.
Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial.
Saito Y, Kelbæk H, Xu B, Hussain Y, Anderson R, Schächinger V, Zheng M, Wijns W, Baumbach A, Lansky AJ. Saito Y, et al. Among authors: hussain y. EuroIntervention. 2021 Jul 20;17(4):e332-e334. doi: 10.4244/EIJ-D-20-00344. EuroIntervention. 2021. PMID: 32482617 Free PMC article. No abstract available.
Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.
Shah T, Abu-Much A, Batchelor WB, Grines CL, Baron SJ, Zhou Z, Li Y, Maini AS, Redfors B, Hussain Y, Wollmuth JR, Basir MB, O'Neill WW, Lansky AJ. Shah T, et al. Among authors: hussain y. JACC Cardiovasc Interv. 2023 Jul 24;16(14):1721-1729. doi: 10.1016/j.jcin.2023.04.036. Epub 2023 Jul 5. JACC Cardiovasc Interv. 2023. PMID: 37409991 Free article.
Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD Studies.
Hussain Y, Kearney KE, Abbott JD, Kereiakes DJ, Di Mario C, Saito S, Cristea E, Riley RF, Fajadet J, Shlofmitz RA, Ali ZA, Klein AJ, Price MJ, Hill JM, Stone GW, Lansky AJ. Hussain Y, et al. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100011. doi: 10.1016/j.jscai.2021.100011. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130137 Free PMC article.
163 results